Audrey Coilly
Prof Audrey Coilly is an expert in Hepatology at Centre Hépato-Biliaire (France). As of October 2026, ScienceLeadR ranks Audrey Coilly in the top 1% of experts worldwide for Liver Transplantation and Tissue Transplantation, and in the top 1% of experts in France for alpha 1-Antitrypsin Deficiency. Audrey Coilly has authored 260 publications, the most recent in 2026, and is an investigator in 13 clinical trials, 8 of them ongoing. SLR score: 999 (community average: 125). How the SLR is computed.
LeadR Profile
Hepatology
Subspecialties: Gastroenterology - Transplantation - Surgery
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Short Biography
Audrey Coilly, MD, PhD, is Professor of Hepatology at Paris-Saclay University and Head of the Hepatology Department and Liver Transplantation Program at Paul Brousse Hospital (AP-HP), France. A clinician-scientist in hepatology, her work spans liver transplantation, acute liver failure, viral hepatitis, and translational research. She also contributes to national leadership in transplantation, medical education, and academic governance.
Organizations
Career arc: 2010 - 2026
Number : 260
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Negative-pressure ICU rooms and pulmonary aspergillosis: room conversion matters. PMID 42864668 — pulmonary aspergillosis, aspergillosis | Crit Care | 2026 | 0 |
| Evaluation of available scoring systems in liver transplantation for severe acute-on-chronic liver failure (ACLF). PMID 42735233 — liver transplantation, mortality, acute-on-chronic liver failure, liver, transplantation, liver failure | Liver Transpl | 2026 | 0 |
| Everolimus and de novo malignancies after liver transplantation: a Nationwide Emulated Trial Using Real-World Data. PMID 42413767 — liver transplantation, incidence, neoplasms, tacrolimus, liver, everolimus, transplants, research, immunosuppression therapy, transplantation | JHEP Rep | 2026 | 0 |
| Pre-liver transplant assessment of patients with acute-on-chronic liver failure: An international survey. PMID 42391791 — research design, liver transplantation, acute-on-chronic liver failure, stress, physiological, ear, angiography, liver, transplants, intensive care units, outpatients, nose, pharynx, colonoscopy, liver failure | JHEP Rep | 2026 | 0 |
| Liver Transplantation for HBV-Related Disease in France: NUC Type Before LT Is Associated With Patient Survival. PMID 42274284 — liver transplantation, liver, viruses, transplantation, infections | Liver Int | 2026 | 0 |
Clinical Studies 13
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Cohort/Consortium Investigators 7
Ongoing Clinical Trials
8 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| Study to learn about the safety of fazirsiran and if it can help people with alpha 1 antitrypsin liver disease with mild liver scarring (fibrosis) 2023-504198-19-00 — liver diseases, safety, fibrosis, alpha 1-antitrypsin deficiency, liver, therapeutics, alpha 1-antitrypsin | Phase 3 | Not yet recruiting | 2024 |
| Establishment of a Biobank for the Evaluation of Rapid Diagnostic Solutions NCT07411729 — registries, skin, warfare, biological warfare agents, disease outbreaks, blood, serum, lymph nodes, bronchoalveolar lavage, biopsy, solutions, lymph, zoonoses, biological warfare, communicable diseases, emerging, blood culture, punctures, tissues, communicable diseases, aspirations, psychological, plasma | N/A | Recruiting | 2024 |
| Prevalence of Alpha 1 Antitrypsin Deficiency in Non Cirrhotic Liver Cancer NCT07145385 — carcinoma, hepatocellular, alpha 1-antitrypsin deficiency, polymerase chain reaction, neoplasms, liver, liver neoplasms, prevalence, alpha 1-antitrypsin, carcinoma | N/A | Not yet recruiting | 2026 |
| LEOPARD Training and Validation Data Collection Study NCT06675604 — liver transplantation, mortality, cholangitis, liver cirrhosis, patient dropouts, data collection, liver, cholangitis, sclerosing, transplants, artificial intelligence, liver cirrhosis, biliary, transplantation, carcinoma | N/A | Recruiting | 2025 |
| Long term Mortality Post Liver Transplantation in the Era of Modern Immunosuppression NCT06636409 — liver diseases, liver transplantation, mortality, liver, risk factors, transplants, records, immunosuppression therapy, transplantation, medical records | N/A | Active not recruiting | 2023 |
LeadR Networks
Main global connection map